ALB and triple-negative breast carcinoma: Considering that paclitaxel-albumin, an agent that can effectively improve the PCR rate for patients with triple negative breast cancer according to some studies15, was used in both groups in our study, including the four patients who obtained PCR in the observation group, we removed the data of these four patients to eliminate the potential confounding factors for analysis.